Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Core Lab Reports Second Quarter 2020 Results From Continuing Operations:

      - COMPANY REVENUE OF $116 MILLION

      - GAAP EPS OF $(0.13); $0.14, EX-ITEMS

      - CORE GENERATES FCF FOR 75TH CONSECUTIVE QUARTER OF $24 MILLION

      - CORE REDUCES NET DEBT BY $23 MILLION

      - CORE AMENDS CREDIT FACILITY

      Core Laboratories N.V. logo (PRNewsFoto/Core Laboratories N.V.)

      News provided by

      Core Laboratories N.V.

      Jul 22, 2020, 17:15 ET

      Share this article

      Share this article


      AMSTERDAM, July 22, 2020 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in second quarter 2020 revenue of $115,700,000.  The financial results for the second quarter of 2020 include a charge of $13,300,000 associated with: 1) severance in connection with on-going cost reduction initiatives, 2) a non-cash inventory write-down, and 3) other non-cash charges.  Core's operating loss was $2,600,000, with a loss per diluted share of $0.13, all in accordance with U.S. generally accepted accounting principles ("GAAP").  Operating income, ex-items, a non-GAAP financial measure, was $10,700,000, yielding operating margins of 9.2% and earnings per diluted share ("EPS"), ex-items, of $0.14.  A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

      Continue Reading
      This graph summarizes the maximum leverage ratio permitted over the relevant period
      This graph summarizes the maximum leverage ratio permitted over the relevant period

      Core's Board of Supervisory Directors ("Board") and the Company's Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures, factors that have high correlation to total shareholder return.  Core's asset-light business model and capital discipline promote capital efficiency and are designed to produce more predictable and superior long-term ROIC.  

      Cost Reduction Initiatives and Company Response to COVID-19 Pandemic

      On 23 June 2020, the Company announced Phase 2 of cost reduction measures in response to market conditions and operational disruptions associated with COVID-19.  Combined, the Phase 1 and Phase 2 cost reduction initiatives amount to reduced cash outflows of approximately $61,000,000, on an annualized basis, and in excess of $15,000,000 on a quarterly basis.  Although substantially implemented throughout the second quarter of 2020, the now expanded cost reduction plan will be completed in the third quarter of 2020, further aligning Core Lab's operations with client activity levels.  As previously announced, annual capital expenditures are expected to be reduced by approximately 50%, as compared to 2019.  The Company will continue to monitor the outlook for the industry and evaluate Core's cost structure accordingly. 

      The following table summarizes the projected impact to cash flow associated with the actions described above.  Compared to 2019, the forecast for 2020 shows reduced cash outflows totaling $142,600,000.

      (in $ millions)


      2019



      Forecast
      2020



      Reduced
      Cash
      Outflows
      vs
      2019



      Annualized
      Reduced
      Cash

      Outflows


      Dividend Payout1


      $

      97.7



      $

      12.4



      $

      (85.3)



      $

      (95.9)


      Capital Expenditures1



      22.3




      11.0




      (11.3)




      (11.3)


      Cost Reduction Initiatives1



      —




      (46.0)




      (46.0)




      (61.0)


      Reduced Cash Outflows


      $

      120.0



      $

      (22.6)



      $

      (142.6)



      $

      (168.2)



















      (1) Reduced dividend policy and reduced 2020 capital expenditure plan announced 16 March 2020. Cost reduction initiatives - Phase 1, announced 22 April 2020, Phase 2, announced 23 June 2020.


      The Company continues to operate as an essential business with timely delivery of products and services to its clients during the COVID-19 global pandemic.  The risks and uncertainties associated with COVID-19 continue to potentially have a material impact to both the Company's and its clients' operations. 

      Liquidity, Free Cash Flow, Dividends and Share Repurchases

      During the second quarter of 2020, Core continued to generate FCF, with cash from operations of $27,000,000 and capital expenditures of $3,100,000, yielding FCF of $23,900,000.  The second quarter of 2020 marks the 75th consecutive quarter that the Company generated positive FCF, despite the challenging market and industry conditions.  Free cash was almost entirely focused towards reducing the Company's debt, as net debt was reduced by $23,000,000 during the second quarter 2020, and by $29,000,000 during the first half of 2020.  Core will continue applying its excess free cash flow towards debt reduction for the foreseeable future. 

      As previously announced on 23 June 2020, in response to the economic events associated with COVID-19 and the related downturn in oil and gas industry activity, Core Lab successfully negotiated an amendment to the Company's Credit Facility (the "Amendment").  The Amendment provides an increase to the maximum leverage ratio (calculated as total net debt divided by trailing twelve months adjusted EBITDA) permitted under the Credit Facility, among other things.

      As of 30 June 2020, the Company has $73,000,000 of excess capacity under its $225,000,000 Credit Facility, and anticipates it will continue to generate positive cash flow and reduce net debt, while maintaining ample liquidity.

      On 28 April 2020, the Board announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on 19 May 2020 to shareholders of record on 8 May 2020.  Dutch withholding tax was deducted from the dividend at a rate of 15%.

      On 17 July 2020, the Board announced a quarterly cash dividend of $0.01 per share of common stock, payable on 10 August 2020 to shareholders of record on 27 July 2020.  Dutch withholding tax will be deducted from the dividend at a rate of 15%.

      Reservoir Description

      Reservoir Description revenue in the second quarter of 2020 was $88,400,000, down 14% sequentially.  Operating income for the second quarter of 2020 on a GAAP basis was $13,500,000, while operating income, ex-items, was $15,100,000, yielding operating margins, ex-items, of 17%, up 200 BPS sequentially.  The decline in revenue on a sequential basis was attributable to continued industry disruptions associated with COVID-19.  On-going efforts to align the Reservoir Description segment with client activity levels helped to mitigate the impact to operating margins.

      Reservoir Description operations are heavily exposed to international and offshore activity, with approximately 80% of its revenue sourced from projects outside the U.S., where core, reservoir fluid and derived product samples originate from international project activity.  For example, during the second quarter of 2020, Core's Middle East operations continued to receive new work on highly specialized core and reservoir fluid projects throughout the region. Core's network of laboratories in the Middle East include strategic locations in Kuwait, United Arab Emirates, Kingdom of Saudi Arabia and Qatar.  Earlier this year Core completed the commissioning of a comprehensive reservoir fluids laboratory in Doha, Qatar, adding to its existing reservoir rock laboratory capabilities. This new fluids laboratory includes Core's proprietary, full visualization, high-pressure, high-temperature, pressure-volume-temperature ("PVT") cell instrumentation.  These highly automated systems are uniquely designed to measure phase behavior of reservoir fluids with high concentrations of H2S and CO2 gases commonly found in the region.  Core expects continued demand for its proprietary laboratory services in the Middle East as a result of several factors, including the resumption of production from the Wafra oilfield, located within the Partitioned Neutral Zone in southern Kuwait, as well as the expansion of the North gas field in Qatar.  Core continues to evaluate additional opportunities for laboratory expansion in the region to meet client requests.

      Also in the second quarter of 2020, industry adoption of Core's proprietary, web-enabled data management system, Reservoir Applied Petrophysical Integrated Data service ("RAPID™"), continued to increase, as the RAPID™ platform was adopted by a national oil company ("NOC") in the Middle East.  RAPID™ provides this NOC with centralized, consistent, and easily accessible data in a secure format.  RAPID™ enables the client to quickly and efficiently organize, archive, retrieve and analyze large quantities of geological, petrophysical, reservoir engineering, and reservoir fluids data, and will serve as the NOC's primary repository for this reservoir data. The RAPID™ platform also allows sophisticated database queries from a user-friendly interface. Coupled with Core Lab's Worldwide Rock Catalog, Core's Relative Permeability Toolkit, and other proprietary data tools, RAPID™ can be used to search for reservoir analogs, predict petrophysical and engineering parameters, and to integrate new laboratory data being acquired as part of on-going analytical programs. Core Lab continues its leadership role in the digitization of the oilfield, connecting data analytics tools, data lakes, and data mesh technologies. As the industry's pioneering database for subsurface reservoir data, RAPID™ has evolved and expanded over decades of commercial application, and has become the primary data platform for a suite of independent, national and international oil companies.

      Production Enhancement

      Production Enhancement operations, which are largely focused on complex completions in unconventional, tight-oil reservoirs in the U.S., as well as conventional offshore projects across the globe, posted second quarter 2020 revenue of $27,300,000, falling 45% sequentially.  By comparison, the second quarter 2020 North American rig count and U.S. land completion activity fell over 60% on a sequential basis. Operating loss on a GAAP basis was $16,300,000, which includes non-cash charges of $11,600,000, associated with inventory write-downs, asset impairments and severance costs. Operating loss, ex-items, was $4,600,000. These results were partially mitigated by cost-control actions during the second quarter of 2020, limiting sequential quarterly decremental margins to 37%. 

      During the second quarter of 2020, Core's Plug-and-Abandonment ("PAC™") energetic technology continued to gain market acceptance in the North Sea and Gulf of Mexico ("GOM") regions. When a well reaches the end of its economic life, an operator will determine a plug-and-abandonment strategy.  Core's PAC™ energetic system technology penetrates a single casing string, or as many as four casing strings, without penetrating the outer casing.  This technique enables the operator to establish circulation in the annular space between casing strings, and set functional cement barriers prior to abandoning the well. Compared with conventional section milling, Core Lab's PAC™ perforating methodology enables significant cost savings by reducing the number of rig days, saving the operator $6,000,000 to $8,000,000 per abandoned well.  PAC™ provides Core's clients with an effective and efficient solution when executing multimillion-dollar plug-and-abandonment programs and demonstrates Core's Production Enhancement ballistic engineers' ability to adapt downhole technological advances to diverse industry needs.

      As a result of the client's success with the PAC™ energetic system technology, Core Lab has been enlisted by additional NOC's to design plug-and-abandonment energetic systems for use in high cost, offshore environments. The Core Lab Engineering Testing Solutions team is receiving upfront funding from its client to design systems specific to each such operator's well design and casing requirements.

      During the second quarter of 2020, Core's SpectraStim™, SpectraScan®, and PackScan® downhole imaging technologies were utilized in a client's deepwater GOM well after a screen-out did not occur during the well completion.  Prior to Core's client attempting a remediation program, Core's downhole imaging diagnostics were utilized to determine if an effective formation frac and annular pack, with ample proppant reserve above the top of the downhole sand control screen, had been achieved.  Sufficient proppant placement in the annulus is required to restrict the migration of formation fines during production, and to keep mobile sand particles from cutting screens, damaging surface facilities, and filling the wellbore.  To reduce operator rig time, Core's engineering team processed the diagnostic analysis within two hours of receiving downhole images from the rig site. 

      Core's conclusion from the diagnostic analysis was that the well did not require a top-off treatment.  After discussions between the Production Enhancement engineering team and client, it was unanimously agreed that an effective frac and competent annular pack with ample proppant reserve had been obtained.  Thus, a remedial top-off treatment costing more than $1,000,000 was not required, nor would it have been operationally successful if attempted. The client acknowledged the quality of Core's diagnostic analysis and the timeliness of execution.

      Return On Invested Capital

      The Company and its Board believe that ROIC is a leading long-term performance metric used by shareholders to determine the relative investment value of publicly traded companies.  Further, the Company and its Board believe that shareholders will benefit if Core consistently performs at high levels of ROIC relative to its Comp Group. Core Lab's commitment to capital stewardship is driven in part by the Company's continuing philosophy of having a low capital-intensive business.

      Events associated with the COVID-19 global pandemic have caused significant disruptions in global markets and economies, with adverse effects throughout the energy sector.  These adverse effects have triggered significant asset impairments for goodwill, intangible assets, inventory and other fixed assets, which further distort underlying financial performance and performance metrics, such as ROIC.   

      The Company's Board has established an internal performance metric of demonstrating superior ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg.  Core Lab recorded $122 million in non-cash charges associated with the impairment of goodwill and intangible assets.  Excluding these non-cash asset impairments, Bloomberg's calculation of Core's ROIC was 8.5%, which continues to be higher than the Company's Weighted Average Cost of Capital ("WACC").  Under the current circumstances and considering the magnitude of the asset and goodwill impairment charges incurred across the energy industry, it is difficult to appropriately determine the underlying relative performance across the Bloomberg Comp Group as compared with Core Lab.

      Industry and Core Lab Outlook

      Although crude-oil prices improved from the lows seen in May, E&P companies further reduced their 2020 capital expenditure plans, especially in the U.S., as witnessed by a steep decline in the frac spread index and an over 60% decline in completion activity.  As the third quarter of 2020 began, U.S. land activity improved slightly from the lows experienced during the middle of the second quarter.  In addition, travel restrictions and supply chain disruptions associated with COVID-19 continue to delay international project activity.

      Core continues to project international activity to be down approximately 10 – 15% year-over-year.  The pace and breadth of recovery from COVID-19 restrictions remains highly uncertain, making it difficult to forecast the level and timing of client activity.  Therefore, Core is unable to provide meaningful quantitative quarterly guidance.  From a qualitative perspective, the Company expects project work and international shipment of products to improve somewhat during the second half of 2020 from the lows experienced mid-second quarter 2020. 

      For Reservoir Description, we expect reservoir fluids analysis, which accounts for more than 65% of this segment's revenue, to be more resilient given this work is not solely tied to drilling and completion of new wells.

      Production Enhancement has a wide range of innovative product offerings with on-going projects unrelated to drilling and completion, including a large international plug and abandonment and well remediation program.  Production Enhancement should track or outperform future improvements in U.S. land completions.

      Earnings Call Scheduled

      The Company has scheduled a conference call to discuss Core's second quarter 2020 earnings announcement.  The call will begin at 7:30 a.m. CDT / 2:30 p.m. CEST on Thursday, 23 July 2020.  To listen to the call, please go to Core's website at www.corelab.com.

      Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance.  The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements regarding the future revenue, profitability, business strategies and developments of the Company made in reliance upon the safe harbor provisions of Federal securities law.  The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business conditions, international markets, international political climates, public health crises, such as the COVID-19 pandemic, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission.  These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements.  Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company.  Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.  The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

      Visit the Company's website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.

      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      (amounts in thousands, except per share data)

      (Unaudited)



      Three Months Ended



      % Variance





      June 30, 2020



      March 31,
      2020



      June 30, 2019



      vs. Q1-20



      vs. Q2-19



      REVENUE


      $

      115,736



      $

      152,400



      $

      169,038



      (24.1)%



      (31.5)%

























      OPERATING EXPENSES:






















      Costs of services and sales



      90,680




      115,131




      124,451



      (21.2)%



      (27.1)%



      General and administrative expense



      9,221




      19,567




      9,801



      (52.9)%



      (5.9)%



      Depreciation and amortization



      5,425




      5,441




      5,786



      (0.3)%



      (6.2)%



      Inventory write-down and impairments



      9,932




      122,204




      —



      (91.9)%



      NM



      Other (income) expense, net



      3,045




      (970)




      992



      NM



      207.0%



      Total operating expenses



      118,303




      261,373




      141,030



      (54.7)%



      (16.1)%

























      OPERATING INCOME (LOSS)



      (2,567)




      (108,973)




      28,008



      NM



      NM



      Interest expense



      3,369




      3,411




      3,714



      (1.2)%



      (9.3)%



      Income (loss) from continuing operations

         before income tax expense



      (5,936)




      (112,384)




      24,294



      NM



      NM



      Income tax expense (benefit)



      (261)




      (4,046)




      4,808



      NM



      NM



      Income (loss) from continuing operations



      (5,675)




      (108,338)




      19,486



      NM



      NM



      Income (loss) from discontinued

         operations, net of income taxes



      —




      —




      7,971



      NM



      NM



      Net income (loss)



      (5,675)




      (108,338)




      27,457



      NM



      NM



      Net income (loss) attributable to non-

         controlling interest



      41




      83




      43



      (50.6)%



      (4.7)%



      Net income (loss) attributable to Core

         Laboratories N.V.


      $

      (5,716)



      $

      (108,421)



      $

      27,414



      NM



      NM

























      Diluted EPS (loss per share) from continuing

         operations


      $

      (0.13)



      $

      (2.44)



      $

      0.43



      NM



      NM

























      Diluted EPS (loss per share) attributable to Core

         Laboratories N.V.


      $

      (0.13)



      $

      (2.44)



      $

      0.61



      NM



      NM

























      Weighted average diluted common

         shares outstanding



      44,470




      44,447




      44,815



      0.1%



      (0.8)%

























      Effective tax rate



      (4)

      %



      (4)

      %



      20

      %


      NM



      NM

























      SEGMENT INFORMATION:












































      Revenue:






















      Reservoir Description


      $

      88,442



      $

      102,702



      $

      105,649



      (13.9)%



      (16.3)%



      Production Enhancement



      27,294




      49,698




      63,389



      (45.1)%



      (56.9)%



      Total


      $

      115,736



      $

      152,400



      $

      169,038



      (24.1)%



      (31.5)%

























      Operating income (loss):






















      Reservoir Description


      $

      13,534



      $

      11,062



      $

      15,878



      22.3%



      (14.8)%



      Production Enhancement



      (16,324)




      (121,299)




      10,424



      NM



      NM



      Corporate and Other



      223




      1,264




      1,706



      NM



      NM



      Total


      $

      (2,567)



      $

      (108,973)



      $

      28,008



      NM



      NM

























      "NM" means not meaningful






















      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      (amounts in thousands, except per share data)

      (Unaudited)



      Six Months Ended



      % Variance





      June 30, 2020



      June 30, 2019







      REVENUE


      $

      268,136



      $

      338,232



      (20.7)%

















      OPERATING EXPENSES:














      Costs of services and sales



      205,811




      251,834



      (18.3)%



      General and administrative expense



      28,788




      27,238



      5.7%



      Depreciation and amortization



      10,866




      11,373



      (4.5)%



      Inventory write-down and impairments



      132,136




      —



      NM



      Other (income) expense, net



      2,075




      3,365



      (38.3)%



      Total operating expenses



      379,676




      293,810



      29.2%

















      OPERATING INCOME (LOSS)



      (111,540)




      44,422



      NM



      Interest expense



      6,780




      7,440



      (8.9)%



      Income (loss) from continuing operations before income tax expense



      (118,320)




      36,982



      NM



      Income tax expense (benefit)



      (4,307)




      (22,802)



      NM



      Income (loss) from continuing operations



      (114,013)




      59,784



      NM



      Income (loss) from discontinued operations, net of income taxes



      —




      8,230



      NM



      Net income (loss)



      (114,013)




      68,014



      NM



      Net income (loss) attributable to non-controlling interest



      124




      90



      37.8%



      Net income (loss) attributable to Core Laboratories N.V.


      $

      (114,137)



      $

      67,924



      NM

















      Diluted EPS (loss per share) from continuing operations


      $

      (2.57)



      $

      1.33



      NM

















      Diluted EPS (loss per share) attributable to Core Laboratories N.V.


      $

      (2.57)



      $

      1.51



      NM

















      Weighted average diluted common shares outstanding



      44,459




      44,848



      (0.9)%

















      Effective tax rate



      (4)

      %



      (62)

      %


      NM

















      SEGMENT INFORMATION:




























      Revenue:














      Reservoir Description


      $

      191,144



      $

      208,941



      (8.5)%



      Production Enhancement



      76,992




      129,291



      (40.5)%



      Total


      $

      268,136



      $

      338,232



      (20.7)%

















      Operating income (loss):














      Reservoir Description


      $

      24,596



      $

      22,057



      11.5%



      Production Enhancement



      (137,623)




      20,336



      NM



      Corporate and Other



      1,487




      2,029



      NM



      Total


      $

      (111,540)



      $

      44,422



      NM

















      "NM" means not meaningful

      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED BALANCE SHEET

      (amounts in thousands)

      (Unaudited) 















      % Variance



      ASSETS:


      June 30,
      2020



      March 31,
      2020



      June 30,
      2019



      vs. Q1-20



      vs. Q2-19

























      Cash and cash equivalents


      $

      20,958



      $

      13,890



      $

      12,546



      50.9%



      67.0%



      Accounts receivable, net



      101,464




      126,872




      134,900



      (20.0)%



      (24.8)%



      Inventory



      41,528




      52,263




      49,311



      (20.5)%



      (15.8)%



      Other current assets



      27,443




      26,682




      28,476



      2.9%



      (3.6)%



      Total Current Assets



      191,393




      219,707




      225,233



      (12.9)%



      (15.0)%

























      Property, plant and equipment, net



      119,866




      123,112




      125,699



      (2.6)%



      (4.6)%



      Right-of-use assets



      70,147




      74,943




      76,290



      (6.4)%



      (8.1)%



      Intangibles, goodwill and other long-term assets, net



      233,035




      228,847




      354,296



      1.8%



      (34.2)%



      Total assets


      $

      614,441



      $

      646,609



      $

      781,518



      (5.0)%



      (21.4)%

























      LIABILITIES AND EQUITY:












































      Accounts payable


      $

      23,693



      $

      37,054



      $

      41,995



      (36.1)%



      (43.6)%



      Short-term operating lease obligations



      12,028




      12,583




      12,968



      (4.4)%



      (7.2)%



      Other current liabilities



      63,563




      58,810




      69,863



      8.1%



      (9.0)%



      Total current liabilities



      99,284




      108,447




      124,826



      (8.4)%



      (20.5)%

























      Long-term debt, net



      286,610




      302,420




      290,022



      (5.2)%



      (1.2)%



      Long-term operating lease obligations



      57,449




      60,162




      62,737



      (4.5)%



      (8.4)%



      Other long-term liabilities



      104,951




      105,506




      111,441



      (0.5)%



      (5.8)%

























      Total equity



      66,147




      70,074




      192,492



      (5.6)%



      (65.6)%



      Total liabilities and equity


      $

      614,441



      $

      646,609



      $

      781,518



      (5.0)%



      (21.4)%




      "NM" means not meaningful

      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (amounts in thousands)

      (Unaudited)



      Three Months Ended




      June 30, 2020



      March 31, 2020



      June 30, 2019


      CASH FLOWS FROM OPERATING ACTIVITIES













      Income (loss) from continuing operations


      $

      (5,675)



      $

      (108,338)



      $

      19,486


      Income (loss) from discontinued operations



      —




      —




      7,971


      Net Income (loss)


      $

      (5,675)



      $

      (108,338)



      $

      27,457


      Adjustments to reconcile net income to net cash provided by operating activities:













      Stock-based compensation



      2,865




      10,530




      3,245


      Depreciation and amortization



      5,425




      5,441




      5,786


      Deferred income tax



      (180)




      (7,374)




      (3,356)


      Inventory write-down and impairments



      9,932




      122,204




      —


      Gain on sale of business



      —




      —




      (1,154)


      Gain on sale of discontinued operations



      —




      —




      (8,808)


      Accounts receivable



      24,288




      4,784




      (2,385)


      Inventory



      987




      (2,285)




      1,492


      Accounts payable



      (12,343)




      132




      (399)


      Other adjustments to net income (loss)



      1,697




      (3,069)




      (4,798)


      Net cash provided by operating activities


      $

      26,996



      $

      22,025



      $

      17,080















      CASH FLOWS FROM INVESTING ACTIVITIES













      Capital expenditures


      $

      (3,066)



      $

      (3,340)



      $

      (7,047)


      Proceeds from sale of business



      —




      —




      2,980


      Proceeds from sale of discontinued operations



      —




      —




      16,642


      Other investing activities



      (206)




      (544)




      (316)


      Net cash provided by (used in) investing activities


      $

      (3,272)



      $

      (3,884)



      $

      12,259















      CASH FLOWS FROM FINANCING ACTIVITIES













      Repayment of debt borrowings


      $

      (26,000)



      $

      (20,000)



      $

      (36,000)


      Proceeds from debt borrowings



      10,000




      17,000




      31,000


      Dividends paid



      (445)




      (11,111)




      (24,395)


      Repurchase of treasury shares



      (198)




      (1,238)




      (604)


      Other financing activities



      (13)




      6




      —


      Net cash used in financing activities


      $

      (16,656)



      $

      (15,343)



      $

      (29,999)















      NET CHANGE IN CASH AND CASH EQUIVALENTS



      7,068




      2,798




      (660)


      CASH AND CASH EQUIVALENTS, beginning of period



      13,890




      11,092




      13,206


      CASH AND CASH EQUIVALENTS, end of period


      $

      20,958



      $

      13,890



      $

      12,546


      CORE LABORATORIES N.V. & SUBSIDIARIES

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (amounts in thousands)

      (Unaudited)



      Six Months Ended




      June 30, 2020



      June 30, 2019


      CASH FLOWS FROM OPERATING ACTIVITIES









      Income (loss) from continuing operations


      $

      (114,013)



      $

      59,784


      Income (loss) from discontinued operations



      —




      8,230


      Net Income (loss)


      $

      (114,013)



      $

      68,014


      Adjustments to reconcile net income to net cash provided by operating activities:









      Stock-based compensation



      13,395




      14,341


      Depreciation and amortization



      10,866




      11,373


      Deferred income tax



      (7,554)




      (35,116)


      Inventory write-down and impairments



      132,136




      —


      Gain on sale of business



      —




      (1,154)


      Gain on sale of discontinued operations



      —




      (8,808)


      Accounts receivable



      29,072




      (6,321)


      Inventory



      (1,298)




      (2,915)


      Accounts payable



      (12,211)




      947


      Other adjustments to net income



      (1,372)




      1,875


      Net cash provided by operating activities


      $

      49,021



      $

      42,236











      CASH FLOWS FROM INVESTING ACTIVITIES









      Capital expenditures


      $

      (6,406)



      $

      (12,230)


      Proceeds from sale of business



      —




      2,980


      Proceeds from sale of discontinued operations



      —




      16,642


      Other investing activities



      (750)




      (338)


      Net cash provided by (used in) investing activities


      $

      (7,156)



      $

      7,054











      CASH FLOWS FROM FINANCING ACTIVITIES









      Repayment of debt borrowings


      $

      (46,000)



      $

      (68,000)


      Proceeds from debt borrowings



      27,000




      68,000


      Dividends paid



      (11,556)




      (48,769)


      Repurchase of treasury shares



      (1,436)




      (1,091)


      Other financing activities



      (7)




      —


      Net cash used in financing activities


      $

      (31,999)



      $

      (49,860)











      NET CHANGE IN CASH AND CASH EQUIVALENTS



      9,866




      (570)


      CASH AND CASH EQUIVALENTS, beginning of period



      11,092




      13,116


      CASH AND CASH EQUIVALENTS, end of period


      $

      20,958



      $

      12,546


      Non-GAAP Information

      Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items.  For this reason, we use certain non-GAAP measures that exclude these Items; and we feel that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statement and filings with the Securities and Exchange Commission.

      Reconciliation of Operating Income, Income from Continuing Operations and Earnings Per Diluted Share from Continuing Operations

      (amounts in thousands, except per share data)

      (Unaudited)



      Operating Income (loss) from Continuing Operations



      Three Months Ended



      June 30, 2020


      March 31, 2020


      June 30, 2019

      GAAP reported


      $

      (2,567)


      $

      (108,973)


      $

      28,008

      Inventory write-down and impairments 1



      9,932



      122,204



      —

      Cost reduction and other charges



      3,415



      1,155



      2,977

      Stock compensation 2



      —



      6,750



      —

      Gain on sale of business



      —



      —



      (1,154)

      Foreign exchange losses (gains)



      (98)



      (576)



      (218)

      Excluding specific items


      $

      10,682


      $

      20,560


      $

      29,613



      Income (loss) from Continuing Operations



      Three Months Ended



      June 30, 2020


      March 31, 2020


      June 30, 2019

      GAAP reported


      $

      (5,675)


      $

      (108,338)


      $

      19,486

      Inventory write-down and impairments 1



      9,495



      113,181



      —

      Cost reduction and other charges



      3,265



      924



      2,381

      Debt issuance cost write-off



      328



      —



      —

      Stock compensation 2



      —



      6,750



      —

      Gain on sale of business



      —



      —



      (1,154)

      Impact of higher (lower) tax rate 3



      (1,208)



      1,663



      181

      Foreign exchange losses (gains)



      (79)



      (461)



      (174)

      Excluding specific items


      $

      6,126


      $

      13,719


      $

      20,720



      Earnings (Loss) Per Diluted Share from Continuing Operations



      Three Months Ended



      June 30, 2020


      March 31, 2020


      June 30, 2019

      GAAP reported


      $

      (0.13)


      $

      (2.44)


      $

      0.43

      Inventory write-down and impairments 1



      0.21



      2.53



      —

      Cost reduction and other charges



      0.07



      0.02



      0.06

      Debt issuance cost write-off



      0.01



      —



      —

      Stock compensation 2



      —



      0.15



      —

      Gain on sale of business



      —



      —



      (0.03)

      Impact of higher (lower) tax rate 3



      (0.02)



      0.04



      —

      Impact on assuming dilution



      —



      0.02



      —

      Foreign exchange losses



      —



      (0.01)



      —

      Excluding specific items


      $

      0.14


      $

      0.31


      $

      0.46











      (1)

      Three months ended June 30, 2020 includes inventory write-down charge of $9.9 million; Three months ended March 31, 2020 includes goodwill impairment charge of $114 million.

      (2)

      Stock compensation expense recognized pursuant to FASB ASC 718 "Stock Compensation" associated with executives reaching eligible retirement age, which is nondeductible in the U.S.

      (3)

      Includes adjustments to reflect tax expense at a normalized rate of 20%. Three months ended June 30, 2020 includes inventory write-down charge; Three months ended March 31, 2020 includes impairment charge and stock compensation expense which are partially deductible and nondeductible.

      Segment Information

      (amounts in thousands)

      (Unaudited)




      Operating Income (Loss) from Continuing Operations



      Three Months Ended June 30, 2020



      Reservoir
      Description


      Production
      Enhancement


      Corporate and
      Other

      GAAP reported


      $

      13,534


      $

      (16,324)


      $

      223

      Foreign exchange losses



      (98)



      135



      (135)

      Cost reduction and other charges



      1,448



      1,967



      —

      Inventory write-down and impairments



      265



      9,667



      —

      Excluding specific items


      $

      15,149


      $

      (4,555)


      $

      88

      Return on Invested Capital

      Return on Invested Capital ("ROIC") is based on Bloomberg's calculation on the trailing four quarters from the most recently reported quarter and the balance sheet of the most recent reported quarter, and is presented based on our belief that this non-GAAP measure is useful information to investors and management when comparing our profitability and the efficiency with which we have employed capital over time relative to other companies. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

      ROIC is defined by Bloomberg as Net Operating Profit (Loss) ("NOP") less Cash Operating Tax ("COT") divided by Total Invested Capital ("TIC"), where NOP is defined as GAAP net income before minority interest plus the sum of income tax expense, interest expense, and pension expense less pension service cost and COT is defined as income tax expense plus the sum of the change in net deferred taxes, and the tax effect on interest expense and TIC is defined as GAAP stockholder's equity plus the sum of net long-term debt, allowance for doubtful accounts, net balance of deferred taxes, income tax payable, and other charges.

      Reconciliation of ROIC

      (amounts in millions, except for ROIC and WACC data)

      (Unaudited)




      Bloomberg



      Effect of non-cash charges


      Excluding non-cash charges


      Net operating profit


      $

      (28.9)



      $

      122.2


      $

      93.3


      Cash operating taxes



      50.1




      (1.4)



      48.7


      Total invested capital



      418.7




      104.1



      522.8














      Return on invested capital



      (18.9)

      %


      NM



      8.5

      %

      Weighted average cost of capital



      6.1

      %








      Free Cash Flow

      Core uses the non-GAAP measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is an important measurement because it represents the cash from operations, in excess of capital expenditures, available to operate the business and fund non-discretionary obligations. Free cash flow is not a measure of operating performance under GAAP, and should not be considered in isolation nor construed as an alternative consideration to operating income, net income, earnings per share, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash flow should not be considered a measure of liquidity. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

      Computation of Free Cash Flow

      (amounts in thousands)

      (Unaudited)









      Three Months Ended


      Six Months Ended




      June 30, 2020


      June 30, 2020


      Net cash provided by operating activities


      $

      26,996


      $

      49,021


      Capital expenditures



      (3,066)



      (6,406)


      Free cash flow


      $

      23,930


      $

      42,615


      SOURCE Core Laboratories N.V.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.